TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/26/05 17:07 | 9/22/05 | SERO | Serologicals Corp | DE | Health | BioPrd | Biological Products, (No Diag | Tilton Lawrence E | GA | D | M.d | 42 | 5.00 | 0 | 8 | 166 | 14 | D | |||||||||||||||
9/26/05 17:07 | 9/22/05 | SERO | Serologicals Corp | DE | Health | BioPrd | Biological Products, (No Diag | Tilton Lawrence E | GA | D | S.d | -192 | 22.60 | 0 | -8 | -38 | 14 | D | |||||||||||||||
8/17/05 16:07 | 8/15/05 | SERO | Serologicals Corp | DE | Health | BioPrd | Biological Products, (No Diag | Tilton Lawrence E | GA | D | M.d | 259 | 11.77 | 0 | 22 | 14 | D | ||||||||||||||||
8/17/05 16:07 | 8/15/05 | SERO | Serologicals Corp | DE | Health | BioPrd | Biological Products, (No Diag | Tilton Lawrence E | GA | D | S.d | -506 | 23.01 | 0 | -22 | -62 | 14 | D | |||||||||||||||
3/19/04 16:21 | 3/19/04 | SERO | Serologicals Corp | DE | Health | BioPrd | Biological Products, (No Diag | Tilton Lawrence E | GA | D | M.d | 412 | 11.77 | 0 | 35 | 20 | D | ||||||||||||||||
3/19/04 16:21 | 3/19/04 | SERO | Serologicals Corp | DE | Health | BioPrd | Biological Products, (No Diag | Tilton Lawrence E | GA | D | S.d | -717 | 20.49 | 0 | -35 | -63 | 20 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |